Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominika Nowis

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
Cancers|September 10, 2020
Non-Hematologic Toxicity of Bortezomib in Multiple Myeloma: The Neuromuscular and Cardiovascular Adverse EffectsElia Pancheri, Valeria Guglielmi, Grzegorz M Wilczynski, et al.
Oncology Reports|December 19, 2001
Potentiated antitumor effects of butyrate and actinomycin D in melanoma model in miceAdam Giermasz, Marcin Makowski, Dominika Nowis, et al.
Cardiovascular Research|October 25, 2008
Sarcolemmal Ca2+-ATPase ability to transport Ca2+ gradually diminishes after myocardial infarction in the ratUrszula Mackiewicz, Michał Maczewski, Anna Konior, et al.
International Journal of Molecular Sciences|May 14, 2022
Ablation of <i>Tmcc2</i> Gene Impairs Erythropoiesis in MiceRanju Kumari, Tomasz M Grzywa, Milena Małecka-Giełdowska, et al.
Cancers|April 13, 2023
Arginase Inhibition Mitigates Bortezomib-Exacerbated Cardiotoxicity in Multiple MyelomaAleksandra Paterek, Marta Oknińska, Zofia Pilch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 19, 2020
Systematic Evaluation of Chemically Distinct Tissue Optical Clearing Techniques in Murine Lymph NodesPaweł Matryba, Anna Sosnowska, Artur Wolny, et al.
Molecular Medicine Reports|July 18, 2017
Selection of an optimal promoter for gene transfer in normal B cellsMagdalena Winiarska, Dominika Nowis, Malgorzata Firczuk, et al.
International Journal of Oncology|April 7, 2004
Cerivastatin demonstrates enhanced antitumor activity against human breast cancer cell lines when used in combination with doxorubicin or cisplatinKatarzyna Kozar, Rafal Kaminski, Magdalena Legat, et al.
Acta Biochimica Polonica|March 11, 2008
Pioglitazone, a PPAR-gamma ligand, exerts cytostatic/cytotoxic effects against cancer cells, that do not result from inhibition of proteasomePiotr Mrówka, Eliza Głodkowska, Izabela Młynarczuk-Biały, et al.
Blood|March 5, 2010
Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicityJacek Bil, Magdalena Winiarska, Dominika Nowis, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Cancers|September 10, 2020
Non-Hematologic Toxicity of Bortezomib in Multiple Myeloma: The Neuromuscular and Cardiovascular Adverse EffectsElia Pancheri, Valeria Guglielmi, Grzegorz M Wilczynski, et al.
Oncology Reports|December 19, 2001
Potentiated antitumor effects of butyrate and actinomycin D in melanoma model in miceAdam Giermasz, Marcin Makowski, Dominika Nowis, et al.
Cardiovascular Research|October 25, 2008
Sarcolemmal Ca2+-ATPase ability to transport Ca2+ gradually diminishes after myocardial infarction in the ratUrszula Mackiewicz, Michał Maczewski, Anna Konior, et al.
International Journal of Molecular Sciences|May 14, 2022
Ablation of <i>Tmcc2</i> Gene Impairs Erythropoiesis in MiceRanju Kumari, Tomasz M Grzywa, Milena Małecka-Giełdowska, et al.
Cancers|April 13, 2023
Arginase Inhibition Mitigates Bortezomib-Exacerbated Cardiotoxicity in Multiple MyelomaAleksandra Paterek, Marta Oknińska, Zofia Pilch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 19, 2020
Systematic Evaluation of Chemically Distinct Tissue Optical Clearing Techniques in Murine Lymph NodesPaweł Matryba, Anna Sosnowska, Artur Wolny, et al.
Molecular Medicine Reports|July 18, 2017
Selection of an optimal promoter for gene transfer in normal B cellsMagdalena Winiarska, Dominika Nowis, Malgorzata Firczuk, et al.
International Journal of Oncology|April 7, 2004
Cerivastatin demonstrates enhanced antitumor activity against human breast cancer cell lines when used in combination with doxorubicin or cisplatinKatarzyna Kozar, Rafal Kaminski, Magdalena Legat, et al.
Acta Biochimica Polonica|March 11, 2008
Pioglitazone, a PPAR-gamma ligand, exerts cytostatic/cytotoxic effects against cancer cells, that do not result from inhibition of proteasomePiotr Mrówka, Eliza Głodkowska, Izabela Młynarczuk-Biały, et al.
Blood|March 5, 2010
Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicityJacek Bil, Magdalena Winiarska, Dominika Nowis, et al.
Pageof 10